AbbVie
ABBV
ABBV
2,669 hedge funds and large institutions have $133B invested in AbbVie in 2021 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 1,275 increasing their positions, 904 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1% more funds holding in top 10
Funds holding in top 10: 138 → 139 (+1)
0.36% less ownership
Funds ownership: 67.34% → 66.98% (-0.36%)
3% less call options, than puts
Call options by funds: $2.28B | Put options by funds: $2.36B
Holders
2,669
Holding in Top 10
139
Calls
$2.28B
Puts
$2.36B
Top Buyers
| 1 | +$830M | |
| 2 | +$372M | |
| 3 | +$312M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$268M |
| 5 |
JPMorgan Chase & Co
New York
|
+$146M |
Top Sellers
| 1 | -$453M | |
| 2 | -$362M | |
| 3 | -$350M | |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$264M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$226M |